Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Relypsa Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Jul 2016 Reuters Investment Profile 12 $20.00

Trading Report for (RLYP). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for RLYP. Entry levels, target prices, and risk controls are integral. In addition, free market anal...

30 Jul 2016 Stock Traders Daily 6 $20.00

Thomson Reuters Stock Report - Relypsa Inc (RLYP-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Jul 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for RLYP

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

24 Jul 2016 ValuEngine, Inc. 11 $25.00

RELYPSA INC (RLYP=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

23 Jul 2016 Pechala's Reports 2 $25.00

Value Graph: RELYPSA -- RLYP

22 Jul 2016 Ford Investor Services, Inc. 1 $12.00

Relypsa, Inc. (RLYP) - Financial Analysis Review

Relypsa, Inc. (RLYP) - Financial Analysis Review Summary Relypsa, Inc. (Relypsa) is a clinical-stage pharmaceutical company t...

19 Jul 2016 GlobalData 43 $300.00

RLYP.OQ - Event Transcript of Relypsa Inc conference call, Jul. 12, 2016 / 2:30PM ET

Edited Event Transcript of RLYP.OQ conference call, Jul. 12, 2016 / 2:30PM ET New York, Jul 18, 2016 (Thomson StreetEve...

12 Jul 2016 Thomson Reuters StreetEvents 6 $75.00

Wright Investors Service Comprehensive Report for Relypsa Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

24 Jun 2016 Wright Reports 59 $75.00

Relypsa, Inc. (RLYP) - Financial Analysis Review

Relypsa, Inc. (RLYP) - Financial Analysis Review Summary Relypsa, Inc. (Relypsa) is a clinical-stage pharmaceutical company t...

16 Jun 2016 GlobalData 43 $300.00